SCHEMBL1920448

SCHEMBL1920448

CCOC(=O)c1cc(C(=O)O)ccn1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 6/20 0.61
KDM5C P41229 3/20 0.61
ALKBH5 Q6P6C2 3/20 0.61
KDM4E B2RXH2 2/20 0.61
KDM6B O15054 2/20 0.61
KDM4C Q9H3R0 2/20 0.61
KDM2A Q9Y2K7 2/20 0.61
KDM3A Q9Y4C1 2/20 0.61
KDM4A O75164 2/20 0.61
KDM5B Q9UGL1 2/20 0.61
TET3 O43151 1/20 0.61
BBOX1 O75936 1/20 0.61
ALDH1A1 P00352 1/20 0.61
MAPT P10636 1/20 0.61
KDM5A P29375 1/20 0.61
ASPH Q12797 1/20 0.61
KDM4D Q6B0I6 1/20 0.61
TET2 Q6N021 1/20 0.61
KDM7A Q6ZMT4 1/20 0.61
KDM8 Q8N371 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29466587 0.90 JMJD6 (0.57) KDM5CKDM4CKDM5BKDM5ACYP1A2
SCHEMBL930636 0.90 JMJD6 (0.57) KDM5CKDM4CKDM5BKDM5ACYP1A2
SCHEMBL16578099 0.87 KDM4E (0.61) FTOKDM5CALKBH5KDM4EKDM6B
SCHEMBL9297593 0.87 CYP1A2 (0.49) FTOKDM5CALKBH5KDM4EKDM6B
SCHEMBL8950955 0.86 MMP2 (0.48) FTOKDM5CALKBH5KDM4EKDM6B
SCHEMBL24604371 0.84 CYP1A2 (0.46) FTOKDM5CALKBH5KDM4EKDM6B
SCHEMBL28033804 0.83 MAPT (0.60) ALDH1A1MAPTCYP1A2JMJD6GABRP
SCHEMBL28990167 0.83 CYP2C9 (0.54) FTOKDM5CALKBH5KDM4EKDM6B
SCHEMBL28271627 0.83 KDM5C (0.69) KDM5CKDM4EKDM6BKDM4CKDM2A
Bromide SCHEMBL9298199 0.82 JMJD6 (0.44) FTOKDM5CALKBH5KDM4EKDM6B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11807886-B2 Process for the preparation of copolymers derived from 2,4- or 2,5-pyridinedicarboxylic acid BIOME BIOPLASTICS LIMITED (GB) 2023-11-07 US disclosed
EP-3307901-B1 PROCESS FOR THE PREPARATION OF 2,4- OR 2,5-PYRIDINEDICARBOXYLIC ACID BIOME BIOPLASTICS LTD (GB) 2022-04-27 EP disclosed
US-11045407-B2 Process for treating keratin fibres with a pyridinedicarboxylic acid compound L'OREAL (FR) 2021-06-29 US disclosed
US-10857087-B2 Process for treating keratin fibres with a polysaccharide and a pyridinedi-carboxylic acid compound L'OREAL (FR) 2020-12-08 US disclosed
CN-104877001-B Antifungal formulations 西尼克斯公司 2020-07-03 CN disclosed
US-20180148752-A1 PROCESS FOR THE PREPARATION OF 2,4- OR 2,5-PYRIDINEDICARBOXYLIC ACID AND COPOLYMERS DERIVED THEREFROM BIOME BIOPLASTICS LIMITED (GB) 2018-05-31 US disclosed
WO-2016202875-A1 PROCESS FOR THE PREPARATION OF 2,4- OR 2,5-PYRIDINEDICARBOXYLIC ACID AND COPOLYMERS DERIVED THEREFROM BIOME BIOPLASTICS LIMITED (GB) 2016-12-22 WO disclosed
WO-2016142635-A1 METHOD FOR THE COSMETIC TREATMENT OF THICK HAIR WITH A PYRIDINE DICARBOXYLIC ACID COMPOUND L'OREAL (FR) 2016-09-15 WO disclosed
US-20160228346-A1 PROCESS FOR TREATING KERATIN FIBRES WITH A POLYSACCHARIDE AND A PYRIDINEDI-CARBOXYLIC ACID COMPOUND L'OREAL (FR) 2016-08-11 US disclosed
US-20160228346-A1 PROCESS FOR TREATING KERATIN FIBRES WITH A POLYSACCHARIDE AND A PYRIDINEDI-CARBOXYLIC ACID COMPOUND L'OREAL (FR) 2016-08-11 US disclosed
CN-103204852-A Heteroaryl amide analogues as P2X7 antagonists LUNDBECK & CO AS H 2013-07-17 CN disclosed
US-8188085-B2 Antifungal agents MERCK SHARP & DOHME CORP. (US) 2012-05-29 US disclosed
US-8188085-B2 Antifungal agents MERCK SHARP & DOHME CORP. (US) 2012-05-29 US disclosed
CN-102176827-A Antifungal formulations MERCK SHARP & DOHME 2011-09-07 CN disclosed
EP-2326181-A1 ANTIFUNGAL AGENTS Merck Sharp & Dohme Corp. (US) 2011-06-01 EP disclosed
CN-101772498-A As P2X7Heteroaryl amide analogs of antagonists LUNDBECK & CO AS H 2010-07-07 CN disclosed
US-20100113439-A1 Antifungal agents MERCK & CO., INC. (US) 2010-05-06 US disclosed
US-20100113439-A1 Antifungal agents MERCK & CO., INC. (US) 2010-05-06 US disclosed
WO-2010019204-A1 ANTIFUNGAL AGENTS MERCK SHARP & DOHME CORP. (US) 2010-02-18 WO disclosed
WO-2010019204-A1 ANTIFUNGAL AGENTS MERCK SHARP & DOHME CORP. (US) 2010-02-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11045407-B2 Process for treating keratin fibres with a pyridinedicarboxylic acid compound KRT18, CUTA, HKDC1 FTO 1830/4885KDM5C 15/4885ALKBH5 1172/4885
US-11807886-B2 Process for the preparation of copolymers derived from 2,4- or 2,5-pyridinedicarboxylic acid HPD, PGD, PCCA FTO 78/4885KDM5C 261/4885ALKBH5 205/4885
US-20160228346-A1 PROCESS FOR TREATING KERATIN FIBRES WITH A POLYSACCHARIDE AND A PYRIDINEDI-CARBOXYLIC ACID COMPOUND KRT18, HKDC1, PHYKPL FTO 889/4885KDM5C 6/4885ALKBH5 1303/4885
US-20100113439-A1 Antifungal agents GMDS, GBA3, UGGT1 FTO 2493/4885KDM5C 3417/4885ALKBH5 3149/4885
US-20180148752-A1 PROCESS FOR THE PREPARATION OF 2,4- OR 2,5-PYRIDINEDICARBOXYLIC ACID AND COPOLYMERS DERIVED THEREFROM HPD, PCCA, MVD FTO 34/4885KDM5C 536/4885ALKBH5 104/4885
US-10857087-B2 Process for treating keratin fibres with a polysaccharide and a pyridinedi-carboxylic acid compound KRT18, HKDC1, PHYKPL FTO 889/4885KDM5C 6/4885ALKBH5 1303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.